144 related articles for article (PubMed ID: 9707372)
21. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
22. Antiviral activity of esterified alpha-lactalbumin and beta-lactoglobulin against herpes simplex virus type 1. Comparison with the effect of acyclovir and L-polylysines.
Sitohy M; Billaudel S; Haertlé T; Chobert JM
J Agric Food Chem; 2007 Dec; 55(25):10214-20. PubMed ID: 17990848
[TBL] [Abstract][Full Text] [Related]
23. Acyclovir Sensitivity and Neurovirulence of Herpes Simplex Virus Type 1 with Amino Acid Substitutions in the Viral Thymidine Kinase Gene, Which Were Detected in the Patients with Intractable Herpes Simplex Encephalitis Previously Reported.
Inagaki T; Satoh M; Fujii H; Yamada S; Shibamura M; Yoshikawa T; Harada S; Takeyama H; Saijo M
Jpn J Infect Dis; 2018 Sep; 71(5):343-349. PubMed ID: 29848849
[TBL] [Abstract][Full Text] [Related]
24. The synergistic effect of IFN-alpha and IFN-gamma against HSV-2 replication in Vero cells is not interfered by the plant antiviral 1-cinnamoyl-3, 11-dihydroxymeliacarpin.
Petrera E; Coto CE
Virol J; 2006 Jun; 3():45. PubMed ID: 16772029
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
[TBL] [Abstract][Full Text] [Related]
26. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
Bourinbaiar AS; Coleman CF
Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
[TBL] [Abstract][Full Text] [Related]
27. Combination of benzo[a]phenothiazines with acyclovir against herpes simplex virus.
Mucsi I; Molnár J; Motohashi N
Int J Antimicrob Agents; 2001 Jul; 18(1):67-72. PubMed ID: 11463529
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone.
Souza TM; De Souza MC; Ferreira VF; Canuto CV; Marques IP; Fontes CF; Frugulhetti IC
Antiviral Res; 2008 Jan; 77(1):20-7. PubMed ID: 17931712
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of the anti-herpetic effect of trichosanthin by acyclovir and interferon.
Zheng YT; Chan WL; Chan P; Huang H; Tam SC
FEBS Lett; 2001 May; 496(2-3):139-42. PubMed ID: 11356198
[TBL] [Abstract][Full Text] [Related]
30. A screening dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus isolates to acyclovir.
Danve C; Morfin F; Thouvenot D; Aymard M
J Virol Methods; 2002 Sep; 105(2):207-17. PubMed ID: 12270654
[TBL] [Abstract][Full Text] [Related]
31. Thymidine kinase mutations conferring acyclovir resistance in herpes simplex type 1 recombinant viruses.
Sergerie Y; Boivin G
Antimicrob Agents Chemother; 2006 Nov; 50(11):3889-92. PubMed ID: 16982796
[TBL] [Abstract][Full Text] [Related]
32. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
Saijo M; Suzutani T; Yoshida I
Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
[TBL] [Abstract][Full Text] [Related]
33. Nucleoside metabolism in herpes simplex virus-infected cells following treatment with interferon and acyclovir, a possible mechanism of synergistic antiviral activity.
O'Brien WJ; Coe EC; Taylor JL
Antimicrob Agents Chemother; 1990 Jun; 34(6):1178-82. PubMed ID: 2393279
[TBL] [Abstract][Full Text] [Related]
34. Synergistic anti-herpes effect of TNF-alpha and IFN-gamma in human corneal epithelial cells compared with that in corneal fibroblasts.
Chen SH; Oakes JE; Lausch RN
Antiviral Res; 1994 Dec; 25(3-4):201-13. PubMed ID: 7710269
[TBL] [Abstract][Full Text] [Related]
35. Synergistic in vitro interactions between (22S,23S)-3beta-bromo-5alpha,22,23-trihydroxystigmastan-6-one and acyclovir or foscarnet against herpes simplex virus type 1.
Talarico LB; Castilla V; Ramirez JA; Galagovsky LR; Wachsman MB
Chemotherapy; 2006; 52(1):38-42. PubMed ID: 16340198
[TBL] [Abstract][Full Text] [Related]
36. Effects of epigallocatechin-3-gallate and acyclovir on herpes simplex virus type 1 infection in oral epithelial cells.
Wu CY; Yu ZY; Chen YC; Hung SL
J Formos Med Assoc; 2021 Dec; 120(12):2136-2143. PubMed ID: 33390306
[TBL] [Abstract][Full Text] [Related]
37. Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity.
Burrel S; Bonnafous P; Hubacek P; Agut H; Boutolleau D
Antiviral Res; 2012 Dec; 96(3):386-90. PubMed ID: 23041200
[TBL] [Abstract][Full Text] [Related]
38. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
[TBL] [Abstract][Full Text] [Related]
39. Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells.
Pierce AT; DeSalvo J; Foster TP; Kosinski A; Weller SK; Halford WP
J Gen Virol; 2005 Sep; 86(Pt 9):2421-2432. PubMed ID: 16099899
[TBL] [Abstract][Full Text] [Related]
40. Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids.
Bestman-Smith J; Boivin G
J Virol; 2003 Jul; 77(14):7820-9. PubMed ID: 12829822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
